Saturday, July 13, 2024

Finland’s Groundbreaking June 2024 Health Technology Assessment Reports Unveiled

Similar articles

The Finnish Coordinating Center for Health Technology Assessment (FinCCHTA) recently announced significant advancements in their evaluations of medical technologies. These announcements included the completion of two rapid hospital assessments in the fields of extracorporeal treatments and endoscopy. These developments mark a critical step forward in understanding and implementing innovative medical treatments that could potentially enhance patient care and outcomes. The assessments, conducted by the renowned Helsinki University Hospital, focused on two cutting-edge treatments. The first assessment evaluated abdominal normothermic regional perfusion (A-NRP) in transplantation.

This technique is particularly innovative as it aims to improve organ preservation and transplantation outcomes by maintaining the organs at a normal body temperature during the transplant process, rather than the traditional cold storage. Such advancements in transplantation technology hold promise for significantly improving the viability and function of transplanted organs, ultimately benefiting patients who require these life-saving procedures. The second assessment targeted the field of oncology, specifically the treatment of pancreatic tumors, through endoscopic ultrasound-guided (EUS) radiofrequency ablation (RFA).

Critical Insights from FinCCHTA’s Recent Health Technology Assessment Reports and Digi-HTA Evaluation

This minimally invasive technique uses high-frequency electrical currents to heat and destroy cancerous tissues. By utilizing endoscopic ultrasound for precise guidance, EUS-RFA aims to enhance the accuracy and effectiveness of tumor ablation, potentially offering a less invasive alternative to traditional surgical methods and reducing recovery times for patients. Despite the successful completion of these assessments, the specific reports detailing the findings and implications of these evaluations are not yet publicly available. This delay in publication has left the medical community, including healthcare professionals, researchers, and policymakers, eagerly awaiting detailed insights.

These reports are anticipated to provide critical data and recommendations that could influence future clinical practices and healthcare policies, further underscoring the importance of these assessments conducted by FinCCHTA and Helsinki University Hospital. Alongside these hospital assessments, FinCCHTA also released a comprehensive Digi-Health Technology Assessment assessment evaluating the Tunstall TSP system. This system is integral for receiving personal alarm alerts and forwarding related assistance tasks via web and desktop applications designed for professional use. Clients use the Lifeline Digital personal alarm device to send alerts, which can be complemented by various sensors and accessories, although these were not included in this particular assessment.

Health Technology Assessment

Implications for Health Technology and Market Access

The Digi-Health Technology Assessment assessment meticulously evaluated the Tunstall TSP system across several subareas, providing the following scores: Effectiveness – promising but more evidence is needed (1), Safety – sufficient (2), Costs – reasonable (2), Data security and data protection – sufficient (2), Usability and accessibility – sufficient (2). With a total score of 9 out of 10, the assessment suggests that the Tunstall TSP system largely meets the evaluation criteria, though additional evidence on its effectiveness is required. This assessment will remain valid until June 2027, giving stakeholders ample time to gather further data and optimize the system’s deployment.

These updates from FinCCHTA are part of a broader effort to enhance transparency and efficiency in health technology assessments across Finland. By conducting rapid hospital assessments and Digi-Health Technology Assessment evaluations, FinCCHTA aims to provide healthcare professionals, policymakers, and the public with accurate and timely information on the effectiveness, safety, and cost-efficiency of new medical technologies. The emphasis on thorough evaluations ensures that only the most reliable and beneficial technologies are adopted in clinical settings, ultimately improving patient outcomes and optimizing resource allocation.


Resource: Mtrconsult, July 05, 2024

You can follow our news on our Telegram and LinkedIn accounts.

Subscribe to our newsletter

To be updated with all the latest news, offers and special announcements.

Latest article